bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.05.18.541398

DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State, Nigeria

Akpabio, C. A.·Ebuh, R. P.·Fatunla, O. E.·Awobode, H. O.·Anumudu, C. I.
View original source ↗Export metadata ↓

Abstract

AbstractSquamous cell carcinoma has been attributed to chronic schistosomiasis and is the predominant type of bladder cancer in schistosomiasis endemic areas. The aim of this study was to assess early promoter DNA methylation in selected genes implicated in schistosomiasis-associated bladder cancer (SABC). A total of 161 urine samples were collected from school aged children in Eggua Community of Ogun State and examined by microscopy for Schistosoma haematobium eggs. From this sample, a subset of 34(21.1%) urine samples positive for S. haematobium eggs and 22 formalin fixed paraffin-embedded bladder cancer tissues obtained from the University College Hospital Ibadan, were subjected to DNA isolation and bisulfite DNA conversion. Quantitative methylation specific PCR was used to determine the methylation status of APC, RAR{beta}2, RASSF1A and TIMP3 in the samples. Methylation in APC, RAR{beta}2, RASSF1A and TIMP3 was observed in 24(70.6%), 18(52.9%), 15(44.1%) and 8(23.5%) of the positive urine samples respectively and in 7(31.8%), 13(59.1%), 17(77.3%) and 8(36.4%) of bladder cancer tissues respectively. APC, RAR{beta}2 and RASSF1A were 5-fold, 2-fold and 27-fold downregulated respectively in positive urine samples and 9-fold, 3-fold and 15-fold downregulated respectively in the bladder cancer tissues. The odds of promoter methylation in RAR{beta}2 (OR: 1.133) were likely even with light infection. Gene promoter DNA methylation in tumour suppressor genes was observed in schistosomiasis cases. Hence, DNA methylation may occur during active Schistosoma haematobium in children. This result may serve as an early non-invasive biomarker to detect and hint at the risk of developing SABC later in life. Author summarySchistosoma haematobium can survive in the host for more than 20 years, during which time it causes damage to the bladder tissues and sometimes with no symptoms. Immune response to the parasite infection is inflammatory and leads to several morbidities like anaemia, undernutrition, dysuria, and female genital sores and may result in malignant transformation (schistosomiasis-associated bladder cancer) which presents in later years. Children are more susceptible to schistosomiasis because of having a naive immune system, making them targets for these morbidities, and including the possibility of developing bladder cancer in later years. DNA methylation which is often the first step in malignant transformation is known to be induced by inflammation during chronic schistosomiasis. Hence, assessing DNA methylation can serve as a biomarker for predicting the risk of developing bladder cancer later in life. In this study, we have established that DNA methylation occurs during childhood schistosomiasis and represents the time when events leading up to malignant transformation may begin. We suggest that once there is a schistosomiasis infection, DNA methylation will occur and unless the disease is treated on time, the individual is at risk of malignant transformation later in life.

Source connections

Explore related subjects

pathologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Akpabio, C. A., Ebuh, R. P., Fatunla, O. E., Awobode, H. O., Anumudu, C. I.. 2023-05-22. DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State, Nigeria. https://doi.org/10.1101/2023.05.18.541398

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events

Background: Autophagy is a homeostatic pathway supporting stress adaptation and is dysregulated in atherosclerosis. Its potential as a biomarker or therapeutic target in atherosclerotic vascular disease (ASVD) remains incompletely defined. We measured autophagic flux in peripheral blood mononuclear cells (PBMCs) from patients with peripheral arterial disease (PAD) or carotid stenosis (CS), compared with healthy controls, and explored clinical outcome associations. Methods: Ninety-four patients with PAD or CS and 19 healthy controls were studied. Autophagic flux was quantified from fresh blood using a validated ex vivo chloroquine inhibition ELISA measuring LC3BII accumulation. Major adverse cardiovascular events (MACE) and major adverse limb events (MALE) were ascertained over a median follow up of 828 days. Results: The ASVD cohort comprised claudication (n = 16), chronic limb threatening ischemia (CLTI; n = 49), and CS (n = 29). Autophagic flux was higher in ASVD than controls (mean 281.4 vs. 182.3 ng LC3BII/mg protein/h; p < 0.0001) and remained independently associated after multivariable adjustment. Within CLTI, concurrent infection was associated with lower flux (p = 0.001), approaching control levels (p = 0.327). In CLTI, higher flux quartiles were associated with lower MACE risk, most strongly for quartile 3 (hazard ratio 0.07 vs. quartile 1, 95% CI 0.01 to 0.50; p = 0.009). Conclusion: Autophagic flux is elevated in PBMCs from ASVD patients, independent of age and sex. Attenuated flux in CLTI with concurrent infection may indicate autophagic exhaustion in advanced disease. The association between higher flux and lower MACE in CLTI suggests prognostic utility, warranting evaluation in larger prospective studies.

pathology↗
bioRxiv2026

Quantitative Model of the Ocular Immune Response during Seasonal Allergic Conjunctivitis

Allergic conjunctivitis is an inflammation of the conjunctiva caused by allergen; it is common disorder affecting up to 40% of the population. In this work, we study seasonal allergic conjunctivitis (SAC), also called "hay fever eyes", which is caused by exposure to airborne pollens. We develop a mathematical model quantifying the ocular immune system response to the allergens. First, we present a simplified qualitative description of the immunopathogenesis of SAC. Then, we express each chosen immunopathological mechanism mathematically to construct a system of thirty-one ordinary differential equations. We compare summary statistics of the predicted observable immune signals to experimental measurements and find our model captures key qualitative features of SAC progression. We then compare our predicted time series of histamine concentration to symptom scores and find a strong correlation suggesting the model predicts relevant clinically trends. Next, we calibrate the model through multi-step process. We find the most influential parameters are the production and depletion rates of IL-4, and the production rates of IL-5 and IL-8. These cytokines are targeted in treatments for asthma, atopic dermatitis, and severe eosinophilic associated disorder and suggest potential therapeutic targets for SAC. Our calibrated model mimics most of the summary statistics of the experimentally observable immune signals with discrepancies for IL-5 and IL-13 indicating that additional immunopathological mechanisms could be important.

pathology↗
bioRxiv2026

Dysregulated Platelet GPIb alpha - VWF Signalling in Abdominal Aortic Aneurysm formation and Progression

Background: Platelets are critical drivers of thrombo-inflammatory responses in different cardiovascular diseases. Abdominal aortic aneurysm (AAA) is a progressive, life-threatening vascular disorder mainly characterised by chronic inflammation, extracellular matrix degradation, and the formation of a platelet-rich intraluminal thrombus (ILT). Experimental and clinical evidence identified platelets as main players in AAA pathology as evidenced by elevated platelet activation and procoagulant activity that critically contribute to AAA progression. Methods: The present study investigated the contribution of glycoprotein (GP)Ib alpha, the von Willebrand factor (VWF)-binding subunit of the platelet GPIb-IX-V complex, to AAA initiation and progression in experimental AAA using the ePPE mouse model and in patients. Results: Genetic ablation of platelet GPIb alpha significantly attenuated early aneurysm expansion in experimental AAA, indicating a critical role for GPIb alpha during the initial stages of aneurysm development. This initial effect was compensated at later time points showing no differences in aneurysm progression between groups. Notably, genetic deletion of GPIb alpha induced a constitutively hyperactive platelet phenotype already in naive mice that was further amplified during experimental AAA. This elevated platelet hyperactivity was mainly due to increased GPVI activation of platelets 28 days post-surgery. To assess the clinical relevance, spatial profiles of human ILT specimens from patients with AAA were analysed. In the ILT, we detected a highly compartmentalised distribution of GPIb alpha and VWF with pronounced enrichment within the luminal layer. In parallel, circulating VWF activity as well as platelet surface expression of GPIb alpha were significantly increased in patients with AAA. Conclusion: Collectively, these findings identify a dysregulated GPIb alpha-VWF axis in human AAA pathology, mainly characterised by enhanced platelet GPIb alpha surface expression and increased activity of circulating VWF.

pathology↗